Physician profile
Ali Mostaghimi
NPI 1922207323
$37,050.39
in general payments reported to CMS, 2019-2025
15 companies · $374 in 2025
The $374 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $523 · 2020: $79.30 · 2021: $35K · 2022: $225 · 2023: $226 · 2024: $362 · 2025: $374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $929 · Entertainment: $33.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $928.70 |
| Entertainment | $33.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $35,419.13 | 2019-2024 | Acuvue |
| Glaukos Corporation | $427.26 | 2022-2025 | Ce-Marked Kxla System, Photrexa, Photrexa Viscous and Photrexa |
| Alcon Vision LLC | $308.24 | 2019-2025 | Argos, Rocklatan |
| Coopervision INC. | $231.50 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $191.89 | 2024-2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $115.77 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $74.76 | 2022-2025 | Vyzulta, Miebo |
| Harrow Eye, LLC | $55.00 | 2024-2025 | Vevye |
| Sun Pharmaceutical Industries INC. | $50.73 | 2025 | |
| Carl Zeiss Meditec USA, INC. | $41.06 | 2023 | Clarus |
| Thea Pharma INC. | $38.55 | 2024-2025 | Iyuzeh |
| Optos, INC. | $33.26 | 2023-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Dompe US, INC. | $25.86 | 2025 | Oxervate |
| Oyster Point Pharma, INC. | $22.32 | 2024 | Ryzumvi, Tyrvaya |
| Visioneering Technologies, INC. | $15.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Mostaghimi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.